Erik Hughes, PhD
Vice President, Applied Science and Technology
Erik Hughes is the Vice President of Applied Science and Technology at Kriya Therapeutics. Previously, Dr. Hughes held roles at Biogen including as Director of Global Process Sciences and Director of North American Manufacturing Sciences. He was responsible for partner relationships, development of second-generation processes, technology transfer, process scale-up, GMP cell banking, process compliance, and lifecycle management across a portfolio of commercial and clinical products. Prior to Biogen, Dr. Hughes worked at Wyeth Research where he was involved in upstream process development for Prevnar13® and a meningococcal group B vaccine.
Dr. Hughes received his PhD in Chemical Engineering and his undergraduate degrees in Chemical Engineering and Economics from Rice University.